The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Somatostatin Inhibits Insulin and Glucagon Secretion via Two Receptor Subtypes: An in Vitro Study of Pancreatic Islets from Somatostatin Receptor 2 Knockout Mice
Open accessAbstract
Somatostatin (SST) potently inhibits insulin and glucagon release from pancreatic islets. Five distinct membrane receptors (SSTR1-5) for SST are known, and at least two (SSTR2 and SSTR5) have been proposed to regulate pancreatic endocrine function. Our current understanding of SST physiology is limited by the receptor subtype selectivity of peptidyl SST analogs, making it difficult to assign a physiological function to an identified SST receptor subtype. To better understand the physiology of SSTRs we studied the in vitro effects of potent subtype-selective nonpeptidyl SST analogs on the regulation of pancreatic glucagon and insulin secretion in wild-type (WT) and in somatostatin receptor 2 knockout (SSTR2KO) mice. There was no difference in basal glucagon and insulin secretion between islets isolated from SSTR2KO and WT mice; however, potassium/arginine-stimulated glucagon secretion was approximately 2-fold higher in islets isolated from SSTR2KO mice. Neither SST nor any SSTR-selective agonist inhibited basal glucagon or insulin release. SST-14 potently inhibited stimulated glucagon secretion in islets from WT mice and much less effectively in islets from SSTR2KO mice. The SSTR2 selective analog L-779,976 inhibited glucagon secretion in islets from WT, but was inactive in islets from SSTR2KO mice. L-817,818, an SSTR5 selective analog, slightly reduced glucagon release in both animal groups, whereas SSTR1, -3, and -4 selective analogs were inactive. SST and L-817,818 inhibited glucose stimulated insulin release in islets from WT and SSTR2KO mice. L-779,976 much less potently reduced insulin secretion from WT islets. In conclusion, our data demonstrate that SST inhibition of glucagon release in mouse islets is primarily mediated via SSTR2, whereas insulin secretion is regulated primarily via SSTR5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
LAMBERTS, S. W. J., KRENNING, E. P., & REUBI, J.-C. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 805
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
AN IMPROVED METHOD FOR ISOLATION OF MOUSE PANCREATIC ISLETS
GOTOH, M., MAKI, T., KIYOIZUMI, T., SATOMI, S., & MONACO, A. P. (1985) · Transplantation · doi:10.1097/00007890-198510000-00018 · Cited by 533
Rohrer, S. P., Birzin, E. T., Mosley, R. T., Berk, S. C., Hutchins, S. M., Shen, D.-M., Xiong, Y., Hayes, E. C., Parmar, R. M., Foor, F., et al. (1998) · Science · doi:10.1126/science.282.5389.737 · Cited by 458
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).
Patel, Y. C., & Srikant, C. B. (1994) · Endocrinology · doi:10.1210/endo.135.6.7988476 · Cited by 348
Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.
Yasuda, K., Rens-Domiano, S., Breder, C. D., Law, S. F., Saper, C. B., Reisine, T., & Bell, G. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88719-7 · Cited by 309
Yamada, Y. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2136 · Cited by 294
Molecular cloning and functional expression of a brain-specific somatostatin receptor.
Bruno, J. F., Xu, Y., Song, J., & Berelowitz, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11151 · Cited by 294
O'Carroll, A. M., Lolait, S. J., König, M., & Mahan, L. C. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09269-7 · Cited by 274
Research works printed but not linked: 13
- Rohrer, 1993, Cloning and characterization of a fourth human somatostatin receptor., Proc Natl Acad Sci USA, 90, 4196, 10.1073/pnas.90.9.4196 · doi:10.1073/pnas.90.9.4196
- Schwabe, 1996, Isolation and characterization of the mouse (Mus musculus) somatostatin receptor type-4-encoding gene (mSSTR4)., Gene, 168, 233, 10.1016/0378-1119(95)00748-2 · doi:10.1016/0378-1119(95)00748-2
- Panetta, 1994, Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28., Mol Pharmacol, 45, 417, 10.1016/S0026-895X(25)10013-8 · doi:10.1016/s0026-895x(25)10013-8
- Aurang, 1997, Somatostatin inhibition of acid and histamine release by activation of somatostatin receptor subtype 2 receptors in rats., J Pharmacol Exp Ther, 281, 245, 10.1016/S0022-3565(24)36613-3 · doi:10.1016/s0022-3565(24)36613-3
- Cordelier, 1997, Characterization of the antiproliferative signal mediation by the somatostatin receptor subtype sst5., Proc Natl Acad Sci USA, 94, 9343, 10.1073/pnas.94.17.9343 · doi:10.1073/pnas.94.17.9343
- Lewin-MJ, 1992, The somatostatin receptor in the GI tract., Annu Rev Physiol, 54, 455, 10.1146/annurev.ph.54.030192.002323 · doi:10.1146/annurev.ph.54.030192.002323
- Mandarino, 1981, Selective effects of somatostatin-14, -25, and -28 on in vitro insulin and glucagon secretion., Nature, 291, 76, 10.1038/291076a0 · doi:10.1038/291076a0
- Fagan, 1998, Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse., Surgery, 124, 254, 10.1016/S0039-6060(98)70128-X · doi:10.1016/s0039-6060(98)70128-x
- Gu, 1997, Coupling specificity between somatostatin receptor sst2A and G proteins: isolation of the receptor-G protein complex with a receptor antibody., Mol Endocrinol, 11, 527, 10.1210/mend.11.5.9926 · doi:10.1210/mend.11.5.9926
- Reubi, 1998, Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets., J Clin Endocrinol Metab, 83, 3746, 10.1210/jcem.83.10.5314 · doi:10.1210/jcem.83.10.5314
- Östenson, 1990, Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas., Regul Pept, 29, 143, 10.1016/0167-0115(90)90077-A · DOI
- Welsh, 1986, Regulation of RNA metabolism in relation to insulin production and oxidative metabolism in mouse pancreatic islets in vitro., Biochim Biophys Acta, 887, 58, 10.1016/0167-4889(86)90122-9 · doi:10.1016/0167-4889(86)90122-9
- Sullivan, 1987, Characterization of somatostatin receptors which mediate inhibition of insulin secretion in RINm5F insulinoma cells., Endocrinology, 121, 544, 10.1210/endo-121-2-544 · doi:10.1210/endo-121-2-544
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“Islets isolated from mice deficient in SSTR2 show no overt changes in basal glucagon or insulin secretion compared with islets isolated from wild-type controls (563).”
BackgroundResultPhysiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes
Quesada, I., Tudurí, E., Ripoll, C., & Nadal, Á. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0290 · Cited by 412
Somatostatin receptors: From signaling to clinical practice
Theodoropoulou, M., & Stalla, G. K. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.07.005 · Cited by 410
Guidelines for Acromegaly Management
Melmed, S., Casanueva, F. F., Cavagnini, F., Chanson, P., Frohman, L., Grossman, A., Ho, K., Kleinberg, D., Lamberts, S., Laws, E., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-011841 · Cited by 343
Hauge-Evans, A. C., King, A. J., Carmignac, D., Richardson, C. C., Robinson, I. C. A. F., Low, M. J., Christie, M. R., Persaud, S. J., & Jones, P. M. (2009) · Diabetes · doi:10.2337/db08-0792 · Cited by 335
Papotti, M., Bongiovanni, M., Volante, M., Allìa, E., Landolfi, S., Helboe, L., Schindler, M., Cole, S., & Bussolati, G. (2002) · Virchows Archiv · doi:10.1007/s00428-002-0609-x · Cited by 330
Regulation and function of somatostatin receptors
Olias, G., Viollet, C., Kusserow, H., Epelbaum, J., & Meyerhof, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02402.x · Cited by 318
Møller, L. N., Stidsen, C. E., Hartmann, B., & Holst, J. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00235-9 · Cited by 307
Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle, M. E., & Egan, J. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.7 · Cited by 256
Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015388 · Cited by 253
SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells
Kailey, B., van de Bunt, M., Cheley, S., Johnson, P. R., MacDonald, P. E., Gloyn, A. L., Rorsman, P., & Braun, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00207.2012 · Cited by 164
Gromada, J., Høy, M., Buschard, K., Salehi, A., & Rorsman, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00519.x · Cited by 120
100 years of glucagon and 100 more
Wewer Albrechtsen, N. J., Holst, J. J., Cherrington, A. D., Finan, B., Gluud, L. L., Dean, E. D., Campbell, J. E., Bloom, S. R., Tan, T. M.-M., Knop, F. K., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05947-y · Cited by 117
de Heer, J., & Holst, J. J. (2007) · Diabetes · doi:10.2337/db06-0738 · Cited by 115
Intra-Islet Somatostatin Regulates Glucagon Release via Type 2 Somatostatin Receptors in Rats
Cejvan, K., Coy, D. H., & Efendic, S. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1176 · Cited by 110
Glucagon secretion from pancreatic α-cells
Briant, L., Salehi, A., Vergari, E., Zhang, Q., & Rorsman, P. (2016) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2016.1156789 · Cited by 109
“In T2DM a-cells, there is a higher Kþ conductance due to increased KATP channel activity (46) and hyperactivation of GIRK channels as the consequence of SST over-secretion (as suggested by the ability of SST antagonists to increase glucagon (38,39)).”
BackgroundParacrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes
Omar-Hmeadi, M., Lund, P.-E., Gandasi, N. R., Tengholm, A., & Barg, S. (2020) · Nature Communications · doi:10.1038/s41467-020-15717-8 · Cited by 105
Chisholm, C., & Greenberg, G. R. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2001 · Cited by 96
Glucose controls glucagon secretion by directly modulating cAMP in alpha cells
Yu, Q., Shuai, H., Ahooghalandari, P., Gylfe, E., & Tengholm, A. (2019) · Diabetologia · doi:10.1007/s00125-019-4857-6 · Cited by 84
Yue, J. T. Y., Burdett, E., Coy, D. H., Giacca, A., Efendic, S., & Vranic, M. (2012) · Diabetes · doi:10.2337/db11-0690 · Cited by 75
Karimian, N., Qin, T., Liang, T., Osundiji, M., Huang, Y., Teich, T., Riddell, M. C., Cattral, M. S., Coy, D. H., Vranic, M., et al. (2013) · Diabetes · doi:10.2337/db13-0164 · Cited by 66
Alpha cell dysfunction in type 1 diabetes
Yosten, G. L. C. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.001 · Cited by 62
Functional identification of islet cell types by electrophysiological fingerprinting
Briant, L. J. B., Zhang, Q., Vergari, E., Kellard, J. A., Rodriguez, B., Ashcroft, F. M., & Rorsman, P. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0999 · Cited by 59
Paracrine regulation of glucagon secretion: the β/α/δ model
Watts, M., Ha, J., Kimchi, O., & Sherman, A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00415.2015 · Cited by 53
Glutamate-mediated signaling in the islets of Langerhans: a thread entangled
Moriyama, Y., & Hayashi, M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.08.002 · Cited by 51
Modeling the pancreatic α-cell: dual mechanisms of glucose suppression of glucagon secretion
Watts, M., & Sherman, A. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.11.4504 · Cited by 45
Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms
Schwetz, T. A., Ustione, A., & Piston, D. W. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2012 · Cited by 40
GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells
Shilleh, A. H., Viloria, K., Broichhagen, J., Campbell, J. E., & Hodson, D. J. (2024) · Peptides · doi:10.1016/j.peptides.2024.171179 · Cited by 39
Hoffman, E. G., D’Souza, N. C., Liggins, R. T., & Riddell, M. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1295639 · Cited by 13
Heterogeneous alpha-cell population modeling of glucose-induced inhibition of electrical activity
Montefusco, F., Cortese, G., & Pedersen, M. G. (2020) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110036 · Cited by 13
Farhy, L. S., & McCall, A. L. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400608 · Cited by 13
Metadata
- Authors
- Strowski, M. Z.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-01-01
- Volume
- 141
- Issue
- 1
- Pages
- 111-117
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2092834109
- Cited by
- 359
- References
- 38
- FWCI
- 13.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.